CD8A and COVID-19: Given all of the above, it is likely that successful vaccines against COVID-19 will require appropriate DC activation, leading to induction of a multifaceted and long-lived type 1 immune response that includes memory CD4+ Th1 cells, CD8+ CTLs, and NAbs.